Genome-wide association study of circulating vitamin D-binding protein

American Journal of Clinical Nutrition

Volumn 99, Issue 6, 2014, Pages 1424-1431

  Moy, Kristin A ^a   Mondul, Alison M ^a   Zhang, Han ^a   Weinstein, Stephanie J ^a   Wheeler, William ^b   Chung, Charles C ^a   Männistö, Satu ^c   Yu, Kai ^a   Chanock, Stephen J ^a   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D BINDING PROTEIN; 25 HYDROXYERGOCALCIFEROL; CALCIFEDIOL; N ACETYLGALACTOSAMINYLTRANSFERASE; NEU5AC N-ACETYLGALACTOSAMINE 2,6-SIALYLTRANSFERASE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; SIALYLTRANSFERASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; COPY NUMBER VARIATION; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BLOOD; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FINLAND; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INTRON; METABOLISM; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

25-HYDROXYVITAMIN D 2; AGED; ALLELES; CALCIFEDIOL; CASE-CONTROL STUDIES; COHORT STUDIES; EXONS; FINLAND; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRONS; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; SIALYLTRANSFERASES; VITAMIN D-BINDING PROTEIN;

EID: 84901684198     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.080309     Document Type: Article

References (39)

1. Chun RF. New perspectives on the vitamin D binding protein. Cell Biochem Funct 2012;30:445-56.
2. Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006;372:33-42.
3. Gomme PT, Bertolini J. Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 2004;22:340-5.
4. Malik S, Fu L, Juras DJ, Karmali M, Wong BY, Gozdzik A, Cole DE. Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci 2013;50:1-22.
5. McGrath JJ, Saha S, Burne TH, Eyles DW. A systemati c review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 2010; 121:471-7.
6. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, et al. Vitamin D and calcium: A systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 2009;183:1-420.
7. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy of Sciences, 2011.
8. Ahn J Yu K Stolzenberg-Solomon R Simon KC McCullough ML Gallicchio L Jacobs EJ Ascherio A Helzlsouer KJacobs KB et al. Genome-wide association study of circulating vitamin D levels, Hum Mol Genet, 2010, 19, 2739-45
9. Wang TJ, Zhang F, Richards JB, Kestenbaum B, Van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association st udy. Lancet 2010;376:180-8.
10. Cooke NE, David EV. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 1985;76:2420-4. 11.
11. Yang F, Brune JL, Naylor SL, Cupples RL, Naberhaus KH, Bowman BH. Human group-specific component (Gc) is a member of the albumin family. Proc Natl Acad Sci USA 1985;82:7994-8.
12. Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 2001;47:753-6.
13. Arna ud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 1993;92:183-8.
14. Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, Nexo E. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): A cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 2005;77:15-22.
15. The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prev ention study: Design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4:1-10.
16. Mondul AM, Weinstein SJ, Virtamo J, Albanes D. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer 2012;107:1589-94.
17. Weinstein SJ, Mondul AM, Kopp W, Rager H, Virtamo J, Albanes D. Circulating 25-hy droxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer 2013;132:2940-7.
18. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D. Impa ct of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: A nested case-control study. Cancer Res 2012;72: 1190-8.
19. Amundadottir L, Kraf t P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, et al. Genome-wide association study identifies variants in the ABO locus associated with susce ptibility to pancreatic cancer. Nat Genet 2009;41:986-90.
20. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, et a l. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-4.
21. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009; 85:679-91.Am J Hum Genet 2011;88:861.
22. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, et al. Multipl e loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40:310-5.
23. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529.
24. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Caporaso N, Kraft P, Chatterjee N. Pathway analy sis by adaptive combination of Pvalues. Genet Epidemiol 2009;33:700-9.
25. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, Madden PA, Heath AC, Martin NG, Montg omery GW, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010;42:565-9.
26. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: A tool for genomewide complex trait analysis. Am J Hum Genet 2011;88:76-82.
27. Al-oanzi ZH, Tuck SP, Raj N, Harrop JS, Summers GD, Cook DB, Francis RM, Datta HK. Assessment of vitamin D status in male osteoporosis. Clin Chem 2006;52:248-54.
28. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrin ol Metab 1986;63:954-9.
29. Viau M, Constans J, Debray H, Montreuil J. Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein. Biochem Biophys Res Commun 1983;117:324-31.
30. Yamamoto N.Macrophage activating factor from vitamin D binding protein US patent No. 5,326,749 1994.
31. Kaseda R, Hosojima M, Sat o H, Saito A. Role of megalin and cubilin in the metabolism of vitamin D(3). Ther Apher Dial 2011;15(suppl 1): 14-7.
32. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI,Willnow TE. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999;96:507-15.
33. Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, Verroust PJ, Aminoff M, de La Chapelle A, Moestrup SK, et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25 (OH) vitamin D(3). Proc Natl Acad Sc i USA 2001;98:13895-900.
34. Willnow TE, Nykjaer A. Cellular uptake of steroid carrier proteins-mechanisms and implications. Mol Cell Endocrinol 2010;316:93-102.
35. Lee YC, Kaufmann M, Kitazume-Kawaguchi S, Kono M, Takashima S, Kurosawa N, Liu H, Pircher H, Tsuji S.Molecular cloning and functional expression of two members of mouse NeuAcalpha2,3Galbeta1,3GalNAc GalNAcalpha2,6-sialy ltransferase family, ST6GalNAc III and IV. J Biol Chem 1999;274:11958-67.
36. Tsuchida A, Ogiso M, Nakamura Y, Kiso M, Furukawa K. Molecular cloning and expression of human ST6GalNAc III: Rest ricted tissue distribution and substrate specificity. J Biochem 2005;138:237-43.
37. Gozdzik A, Zhu J, Wong BY, Fu L, Cole DE, Parra EJ. Association of vitamin D binding protein (VDBP) po lymorphisms and serum 25(OH) D concentrations in a sample of young Canadian adults of different ancestry. J Steroid Biochem Mol Biol 2011;127:405-12.
38. Borges CR, Jarvis JW, Oran PE, Nelson RW. Population studies of vitamin D binding protein microheterogeneity by mass spectrometry lead to characterization of its genotype-dependent O-glycosylation patterns. J Proteome Res 2008;7:4143-53.
39. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991-2000.